{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1047.543","meta":{"versionId":"7","lastUpdated":"2020-06-30T19:27:49.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.543","version":"20200319","name":"Bevacizumab injection","status":"active","date":"2020-03-19T01:00:18-04:00","publisher":"ASRS Quality Measure Development Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1657066","display":"4 ML bevacizumab 25 MG/ML Injection"},{"code":"1657073","display":"16 ML bevacizumab 25 MG/ML Injection"},{"code":"2046140","display":"16 ML bevacizumab-awwb 25 MG/ML Injection"},{"code":"2046148","display":"4 ML bevacizumab-awwb 25 MG/ML Injection"}]}]}}